ARCHIVES

Panel Says Tamoxifen Remains Standard for Preventing Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 21 | May 24, 2002

Download PDF Visit The Full Archive

Related Articles

FDA To Expand Disclosure For Advisory Committee Members

April 23, 2010

MD Anderson’s Balance Sheet is Issue No. 1 For DePinho’s “Moon Shots Program”

October 12, 2012

NCI Advisors Approve Plans To Continue Current Research Programs.

July 3, 2008

SWOG Plans Increase in Payments to Centers for Trial Accrual.

May 25, 2007

Report: Rising Treatment Costs Due to 340B Discounts

May 16, 2014

In Brief: Revlon Foundation Gives $7.5 Million To UCA for Women’s Health Research, Breast Cancer

December 16, 1994